We then combined the clinicopathological information of patients in the TCGA database and confirmed that the expression of TPO gene in PTC patients was associated with their lymph node metastasis and recurrence, and the higher the expression of TPO, the lower their lymph node metastasis rate and the lower their recurrence rate. The gene discussed is TPO; the disease is metastatic malignant neoplasm in the lymph nodes.